Skip to main content
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
29.84
+0.25 (0.84%)
Feb 27, 2026, 4:00 PM EST - Market closed

Assembly Biosciences Revenue

Assembly Biosciences had revenue of $10.79M in the quarter ending September 30, 2025, with 57.62% growth. This brings the company's revenue in the last twelve months to $37.19M, up 31.30% year-over-year. In the year 2024, Assembly Biosciences had annual revenue of $28.52M with 298.16% growth.

Revenue (ttm)
$37.19M
Revenue Growth
+31.30%
P/S Ratio
12.69
Revenue / Employee
$509,466
Employees
73
Market Cap
471.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 202079.11M63.14M395.55%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 161.32M
Invivyd 50.04M
Lineage Cell Therapeutics 10.82M
Prothena Corporation 9.68M
4D Molecular Therapeutics 120.00K
Lyell Immunopharma 41.00K
vTv Therapeutics 17.00K
Revenue Rankings

ASMB News

More News